Effects of 5-Aza-CdR on the proliferation of human breast cancer cell line MCF-7 and on the expression of Apaf-1 gene

Abstract

Hypermethylation in the promoter region of tumor suppressor genes is a common mechanism of gene silencing, which tends to occur in cancer. The effects of 5-Aza-2′-deoxycytidine (5-Aza-CdR), a specific DNA methyltransferase inhibitor, on the cell proliferation of human breast cancer cell line MCF-7 and on the expression of Apaf-1 gene were investigated. Human MCF-7 cells were incubated with increasing concentrations of 5-Aza-CdR for 12 to 120 h. The growth inhibition rates of MCF-7 cells were detected by MTT assay. Changes of cell cycle distribution and apoptotic rates of MCF-7 cells were determined by flow cytometry. The expressions of DNA methyltransferase 3b mRNA and Apaf-1 mRNA were measured by reverse transcription polymerase chain reaction (RT-PCR). Meanwhile, the expression of Apaf-1 protein was detected by Western blotting. The results showed that 5-Aza-CdR significantly inhibited the growth of MCF-7 cells and the growth inhibition rate of MCF-7 cells was significantly enhanced with the concentration of 5-Aza-CdR and the action time. Flow cytometry indicated that 5-Aza-CdR could significantly induce G₁/S cell cycle arrest and increase the apoptosis rate of MCF-7 cells. The mRNA and protein expressions of Apaf-1 were up-regulated in MCF-7 cells treated with 5-Aza-CdR, which was accompanied by down-regulation of DNA methyltransferase 3b mRNA. It is concluded that 5-Aza-CdR might retard the growth of tumor cells and promote the apoptosis of MCF-7 breast cancer cells by inhibiting the expression of DNA methyltransferase 3b and re-activating the Apaf-1 gene expression.

Keywords

Apaf-1 gene / breast cancer / DNA methyltransferase

References

[1] ReinholzM.M., BruzekA.K., VisscherD.W., et al.. Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response. Lancet Oncol, 2009, 10(3): 267-277

[2] MetgeB.J., FrostA.R., KingJ.A., et al.. Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer. Clin Exp Metastasis, 2008, 25(7): 753-763

[3] PotapovaA., HoffmanA.M., GodwinA.K., et al.. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer. Cancer Res, 2008, 68(4): 998-1002

[4] MondragónL., OrzáezM., SanclimensG., et al.. Modulation of cellular apoptosis with apoptotic protease-activating factor 1 (Apaf-1) inhibitors. J Med Chem, 2008, 51(3): 521-529

[5] ChristophF., KempkensteffenC., WeikertS., et al.. Methylation of tumor suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer. Br J Cancer, 2006, 95(12): 1701-1707

[6] ChristophF., HinzS., KempkensteffenC., et al.. mRNA expression profiles of methylated APAF-1 and DAPK-1 tumor suppressor genes uncover clear cell renal cell carcinomas with aggressive phenotype. J Urol, 2007, 178(6): 2655-2659

[7] Del PoetaG., BrunoA., Del PrincipeM.I., et al.. Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia. Curr Cancer Drug Targets, 2008, 8(3): 207-222

[8] ZuoS., ChenY., XuL., et al.. Re-expression of RASSF1A by 5-Aza-CdR induced demethylation of the promoter region in human biliary tract carcinoma cells. J Huazhong Univ Sci Technol [Med Sci], 2007, 27(3): 281-284

[9] LaiF.J., HuangS.S., HsiehM.C., et al.. Upregulation of neuronal nitric oxide synthase mRNA and protein in adrenal medulla of water-deprived rats. J Histochem Cytochem, 2005, 53(1): 45-53

[10] ZhangB., HuangT., LiuK.. Effects of 5-Aza-CdR on cell proliferation of breast cancer cell line MDA-MB-435S and expression of maspin gene. J Huazhong Univ Sci Technolog [Med Sci], 2007, 27(5): 543-546

[11] SheltonB.P., MissoN.L., ShawO.M., et al.. Epigenetic regulation of human epithelial cell cancers. Curr Opin Mol Ther, 2008, 10(6): 568-578

[12] WuY., MengL., WangH., et al.. Regulation of DNA methylation on the expression of the FHIT gene contributes to cervical carcinoma cell tumorigenesis. Oncol Rep, 2006, 16(3): 625-629

[13] KoE., KimY., KimS.J., et al.. Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev, 2008, 17(9): 2260-2267

[14] JeongD.H., YoumM.Y., KimY.N., et al.. Promoter methylation of p16, DAPK, CDH1, and TIMP-3 genes in cervical cancer: correlation with clinicopathologic characteristics. Int J Gynecol Cancer, 2006, 16(3): 1234-1240

[15] JungY., ParkJ., KimT.Y., et al.. Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy. J Mol Med, 2007, 85(10): 1137-1148

[16] ChengX., BlumenthalR.M.. Mammalian DNA methyltransferases: a structural perspective. Structure, 2008, 16(3): 341-350

[17] ShafieiF., RahnamaF., PawellaL., et al.. DNMT3A and DNMT3B mediate autocrine hGH repression of plakoglobin gene transcription and consequent phenotypic conversion of mammary carcinoma cells. Oncogene, 2008, 27(18): 2602-2612

[18] CheethamS., TangM.J., MesakF., et al.. SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2′-deoxycytidine to increase SPARC expression and improve therapy response. Br J Cancer, 2008, 98(11): 1810-1819

[19] JainN., RossiA., Garcia-ManeroG.. Epigenetic therapy of leukemia: An update. Int J Biochem Cell Biol, 2009, 41(1): 72-80

[20] WuY., MengL., WangH., et al.. Regulation of DNA methylation on the expression of the FHIT gene contributes to cervical carcinoma cell tumorigenesis. Oncol Rep, 2006, 16(3): 625-629

[21] JohnsonC.E., HuangY.Y., ParrishA.B., et al.. Differential Apaf-1 levels allow cytochrome C to induce apoptosis in brain tumors but not in normal neural tissues. Proc Natl Acad Sci USA, 2007, 104(52): 20 820-20 825

[22] MondragónL., OrzáezM., SanclimensG., et al.. Modulation of cellular apoptosis with apoptotic protease-activating factor 1 (Apaf-1) inhibitors. J Med Chem, 2008, 51(3): 521-529

[23] HinzS., KempkensteffenC., WeikertS., et al.. EZH2 polycomb transcriptional repressor expression correlates with methylation of the APAF-1 gene in superficial transitional cell carcinoma of the bladder. Tumour Biol, 2007, 28(3): 151-157

[24] Benbrahim-TallaaL., WaterlandR.A., DillA.L., et al.. Tumor suppressor gene inactivation during cadmium-induced malignant transformation of human prostate cells correlates with overexpression of de novo DNA methyltransferase. Environ Health Perspect, 2007, 115(10): 1454-1459

[25] DengT., ZhangY.. Possible involvement of activation of P53/P21 and demethylation of RUNX 3 in the cytotoxicity against Lovo cells induced by 5-Aza-2′-deoxycytidine. Life Sci, 2009, 84(9–10): 311-320